Brandon Folkes
Stock Analyst at H.C. Wainwright
(1.00)
# 3,935
Out of 5,058 analysts
550
Total ratings
39%
Success rate
-0.7%
Average return
Main Sectors:
Stocks Rated by Brandon Folkes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Reiterated: Buy | $15.62 → $15.64 | $9.36 | +67.05% | 20 | Oct 15, 2026 | |
| CNTB Connect Biopharma Holdings | Reiterated: Buy | $7 | $0.909 | +670.08% | 21 | Oct 8, 2026 | |
| RANI Rani Therapeutics Holdings | Reiterated: Buy | $11 | $0.6702 | +1,541.30% | 13 | Oct 6, 2026 | |
| SGMT Sagimet Biosciences | Reiterated: Buy | $29 | $7.55 | +284.36% | 13 | Oct 5, 2026 | |
| ENTA Enanta Pharmaceuticals | Reiterated: Buy | $20 | $11.18 | +78.89% | 13 | Sep 23, 2026 | |
| ANIP ANI Pharmaceuticals | Reiterated: Buy | $121 | $70.16 | +72.46% | 24 | Sep 21, 2026 | |
| COLL Collegium Pharmaceutical | Reiterated: Buy | $60 | $22.51 | +166.55% | 42 | Sep 21, 2026 | |
| DERM Journey Medical | Reiterated: Buy | $13 | $5.28 | +146.21% | 10 | Sep 21, 2026 | |
| MIST Milestone Pharmaceuticals | Reiterated: Buy | $8 | $0.7879 | +915.36% | 17 | Sep 21, 2026 | |
| MNKD MannKind | Reiterated: Buy | $10 | $3.02 | +231.13% | 26 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.586 | +1,265.19% | 10 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.06 | +183.02% | 21 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $12.06 | +99.00% | 15 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12.84 | $1.60 | +702.63% | 15 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $5.66 | +218.02% | 10 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $9.77 | +2.35% | 9 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $10.23 | +154.15% | 16 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $0.4012 | +149.25% | 5 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.362 | - | 40 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $7.39 | +75.91% | 13 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $20.25 | +196.30% | 7 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $18.43 | +79.06% | 26 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $4.83 | +169.15% | 11 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.82 | +449.45% | 3 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $7.00 | +71.43% | 14 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $34.16 | +40.52% | 7 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $200 | $3.00 | n/a | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $7.66 | n/a | 5 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 → $16 | $6.91 | n/a | 29 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $4 | $2.24 | n/a | 5 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $10 | $0.735 | n/a | 2 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 3 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $37 → $33 | $0.11 | n/a | 18 | Mar 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $15 | $2.13 | n/a | 15 | Feb 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $237.82 | n/a | 1 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $40 | $0.4862 | n/a | 2 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $0.0002 | n/a | 1 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $50 | $0.066 | n/a | 3 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $22 → $32 | $39.08 | n/a | 12 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $25 | $35.14 | n/a | 3 | Nov 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $210 | $209.65 | n/a | 10 | Oct 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $8 | $0.000001 | n/a | 4 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $35.12 | n/a | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $12 | $9.60 | n/a | 9 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $33 | $19.47 | n/a | 2 | Dec 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $30 | $38.02 | n/a | 2 | Sep 12, 2016 |
Eupraxia Pharmaceuticals Inc.
Oct 15, 2026
Reiterated: Buy
Price Target: $15.62 → $15.64
Current: $9.36
Upside: +67.05%
Connect Biopharma Holdings
Oct 8, 2026
Reiterated: Buy
Price Target: $7
Current: $0.909
Upside: +670.08%
Rani Therapeutics Holdings
Oct 6, 2026
Reiterated: Buy
Price Target: $11
Current: $0.6702
Upside: +1,541.30%
Sagimet Biosciences
Oct 5, 2026
Reiterated: Buy
Price Target: $29
Current: $7.55
Upside: +284.36%
Enanta Pharmaceuticals
Sep 23, 2026
Reiterated: Buy
Price Target: $20
Current: $11.18
Upside: +78.89%
ANI Pharmaceuticals
Sep 21, 2026
Reiterated: Buy
Price Target: $121
Current: $70.16
Upside: +72.46%
Collegium Pharmaceutical
Sep 21, 2026
Reiterated: Buy
Price Target: $60
Current: $22.51
Upside: +166.55%
Journey Medical
Sep 21, 2026
Reiterated: Buy
Price Target: $13
Current: $5.28
Upside: +146.21%
Milestone Pharmaceuticals
Sep 21, 2026
Reiterated: Buy
Price Target: $8
Current: $0.7879
Upside: +915.36%
MannKind
Sep 21, 2026
Reiterated: Buy
Price Target: $10
Current: $3.02
Upside: +231.13%
Sep 21, 2026
Reiterated: Buy
Price Target: $8
Current: $0.586
Upside: +1,265.19%
Sep 21, 2026
Reiterated: Buy
Price Target: $3
Current: $1.06
Upside: +183.02%
Sep 21, 2026
Reiterated: Buy
Price Target: $24
Current: $12.06
Upside: +99.00%
Sep 21, 2026
Reiterated: Buy
Price Target: $12.84
Current: $1.60
Upside: +702.63%
Sep 21, 2026
Reiterated: Buy
Price Target: $18
Current: $5.66
Upside: +218.02%
Sep 21, 2026
Reiterated: Buy
Price Target: $10
Current: $9.77
Upside: +2.35%
Sep 21, 2026
Reiterated: Buy
Price Target: $26
Current: $10.23
Upside: +154.15%
Aug 18, 2026
Reiterated: Hold
Price Target: $1
Current: $0.4012
Upside: +149.25%
Aug 17, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.362
Upside: -
Aug 14, 2026
Reiterated: Buy
Price Target: $13
Current: $7.39
Upside: +75.91%
Aug 14, 2026
Reiterated: Buy
Price Target: $60
Current: $20.25
Upside: +196.30%
Aug 13, 2026
Reiterated: Buy
Price Target: $33
Current: $18.43
Upside: +79.06%
Aug 13, 2026
Reiterated: Buy
Price Target: $13
Current: $4.83
Upside: +169.15%
Aug 13, 2026
Reiterated: Buy
Price Target: $10
Current: $1.82
Upside: +449.45%
Aug 11, 2026
Reiterated: Buy
Price Target: $12
Current: $7.00
Upside: +71.43%
Aug 4, 2026
Reiterated: Buy
Price Target: $48
Current: $34.16
Upside: +40.52%
Mar 4, 2025
Reiterated: Buy
Price Target: $8 → $200
Current: $3.00
Upside: n/a
Nov 14, 2024
Initiated Coverage: Buy
Price Target: $5
Current: $7.66
Upside: n/a
Aug 22, 2024
Initiated Coverage: Buy
Price Target: $23 → $16
Current: $6.91
Upside: n/a
May 3, 2024
Reiterated: Buy
Price Target: $3 → $4
Current: $2.24
Upside: n/a
May 12, 2023
Reiterated: Buy
Price Target: $20 → $10
Current: $0.735
Upside: n/a
Mar 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Mar 13, 2023
Reiterated: Hold
Price Target: $37 → $33
Current: $0.11
Upside: n/a
Feb 9, 2023
Reiterated: Buy
Price Target: $22 → $15
Current: $2.13
Upside: n/a
Feb 3, 2023
Reiterated: Buy
Price Target: $48
Current: $237.82
Upside: n/a
Nov 22, 2022
Reiterated: Buy
Price Target: $22 → $40
Current: $0.4862
Upside: n/a
Nov 2, 2022
Initiated Coverage: Buy
Price Target: $5
Current: $0.0002
Upside: n/a
Mar 31, 2022
Reiterated: Buy
Price Target: $5 → $50
Current: $0.066
Upside: n/a
Jan 27, 2022
Upgraded: Buy
Price Target: $22 → $32
Current: $39.08
Upside: n/a
Nov 4, 2021
Reiterated: Buy
Price Target: $23 → $25
Current: $35.14
Upside: n/a
Oct 6, 2021
Reiterated: Buy
Price Target: $210
Current: $209.65
Upside: n/a
Aug 9, 2021
Reiterated: Buy
Price Target: $6 → $8
Current: $0.000001
Upside: n/a
Jun 30, 2021
Initiated Coverage: Buy
Price Target: $45
Current: $35.12
Upside: n/a
May 6, 2021
Reiterated: Buy
Price Target: $18 → $12
Current: $9.60
Upside: n/a
Dec 15, 2020
Reiterated: Buy
Price Target: $25 → $33
Current: $19.47
Upside: n/a
Sep 12, 2016
Reiterated: Buy
Price Target: $34 → $30
Current: $38.02
Upside: n/a